VivoSeq
Oncology

Oncology

0

Pipeline Programs↗

10

Active Trials↗

3

Companies Involved↗

Oncology is an early-stage landscape with 0 programs across 3 companies. The most active players are AstraZeneca, Roche, Pfizer.

Intelligence

Pipeline Metrics

Competitive Density

27/100

Pipeline Velocity

25/100

Mech. Concentration

N/A

Completion Rate

70/100

Attrition Rate

9/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

AstraZeneca logo

AstraZeneca

0 programs

PreclinicalRoche logo

Roche

0 programs

PreclinicalPfizer logo

Pfizer

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

22

clinical trials

Completed7 · 32%
Recruiting4 · 18%
Active, not recruiting4 · 18%
Not yet recruiting2 · 9%
Unknown status2 · 9%
Suspended1 · 5%
Other2 · 9%

Clinical Trials

Trial Activity

22 trials

PRE-I-SPY Phase I/Ib Oncology Platform Program
Recruiting·QQuantumLeap Healthcare Collaborative·Phase 1·NCT05868226·124 enrolled
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
Recruiting·Roche logoRoche·Phase 2·NCT04589845·920 enrolled
Oncology, Undernutrition and Sensoriality: Links, Mechanisms and Levers for Action
Recruiting·—·N/A·NCT06600295·306 enrolled
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
Recruiting·UUniversity of Rochester·Preclinical·NCT06697600·1,020 enrolled
Emulation of the CheckMate 017/057 (NCT01642004 and NCT01673867) Trials Using Specialty Oncology Electronic Health Records Databases
Active, not recruiting·—·N/A·NCT07485166·810 enrolled
Emulation of the KEYNOTE-042 (NCT02220894) Trial Using Specialty Oncology Electronic Health Records Databases
Active, not recruiting·—·N/A·NCT07485179·770 enrolled
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
Active, not recruiting·AstraZeneca logoAstraZeneca·Phase 3·NCT04421963·185 enrolled
Impact of an Onco-haematology Vigilance Card in the Optimisation of the Town-hospital Relationship.
Active, not recruiting·UUniversity Hospital, Limoges·N/A·NCT04931329·100 enrolled
Real-world Trial of Individualized Precision Oncology
Not yet recruiting·UUniversity of California, San Diego·Phase 2·NCT07346209·280 enrolled
Promoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell Carcinoma
Not yet recruiting·RRadboud University Medical Center·Preclinical·NCT07680556·30 enrolled
Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery
Completed·UUniversity of Wisconsin, Madison·Phase 2·NCT01444924·75 enrolled
Emulation of the MONARCH-3 Trial Using Specialty Oncology Electronic Health Records Databases
Completed·—·N/A·NCT07225790·3,883 enrolled
Indo-cyanine Green (ICG) in Paediatric Oncology MIS
Completed·BBirmingham Women's and Children's NHS Foundation Trust·Phase 4·NCT04854018·20 enrolled
E. Coli Nissle in Oncology
Completed·UUniversity of Hohenheim·Phase 3·NCT02706184·20 enrolled
Emulation of the FLAURA (NCT02296125) Trial Using Specialty Oncology Electronic Health Records Databases
Completed·—·N/A·NCT06675695·4,864 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)